Immix Biopharma, Inc.
Home - IMMIX BIOPHARMA INC
New Hope for relapsed/refractory AL Amyloidosis ASH Presentation PressRelease Corporate Presentation KOL Event to Discuss ASH 2025 NXC-201 NEXICART-2 Phase 2 Clinical Results Oral Presentation and landscape in relapsed/refractory AL Amyloidosis Hear it From the Media ASCO Post Interview: Shahzad Raza, MD (Cleveland Clinic) Memorial Sloan Kettering: Strong Results for NXC-201 at ASCO Cleveland Clinic:
Company details
- Sector
- Retail & E-commerce
- Categories
- e-commerce
- Address
- United States
- Website
- immixbio.com
Reviews
No reviews yet.
Domain and WHOIS record
- Domain
- immixbio.com
- Registrar
- Register.com - Network Solutions, LLC
- Registered
- 27 Feb 2012
- Expires
- 27 Feb 2027
- Record updated
- 28 Jan 2026
- Name servers
- dns101.register.com, dns102.register.com
- DNSSEC
- Not signed